All mutations were found to affect the ability of CHIP to promote N-methyl-D-aspartate receptor subunit degradation in vitro, which was suggested to be the underlying mechanism for the development of ARCA in these patients. This evidence concerns the gene STUB1 and autosomal recessive cerebellar ataxia.